Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05737914

Bilateral Endoscopic Thoracic T3 Sympathectomy Versus T3 Radiofrequency Ablation for Primary Palmar Hyperhidrosis

Conditions: Primary Palmar Hyperhydrosis

Sex: All
Ages: 18 Years – 45 Years
Phase: NA
Enrollment: 68
Sponsor: Ain Shams University

Location: Egypt

Summary

Primary hyperhidrosis disease is characterized by much more sweating above the needs for thermoregulation, which is worsen by increased temperature and emotional factors it can be seen in the palms of the hands, soles of the feet/ face and so on.Hyperhidrosis usually starts since childhood and continuous throughout life aggravated by emotional stress or by high environmental temperature.Many lines of treatment were tried such as anticholinergic drug, physiotherapy. Endoscope thoracic sympathectomy and radio frequency with phenol injection.

Eligibility Criteria

Inclusion Criteria:Patients with primary palmar hyperhydrosis.Patients with American society classification 1 and 2.Exclusion Criteria:Patient refusal.Previous sympathectomy either endoscopic or by radiofrequency.Previous sternotomy operation.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05737914). StuddyBuddy aggregates publicly available trial information.